Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

Clinical trial NCT04134884 · COMPLETED

Trial details

NCT number: NCT04134884
Sponsor: Kathy Miller
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Triple Negative Breast Cancer Hormone Receptor Positive Tumor

Start date: 2020-04-01
Primary completion: 2024-01-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.